title: [Screening of natural immunosuppressors by their ability to modify steroid synthesis in hepatocytes].
abstract: In the programme for screening sterol synthesis inhibitors with the use of actinomycetes and fungi 702 strains were tested. The effect of alcohol extracts of the mycelium of fungi and actinomycetes at a dilution of 1/10(3) on sterol synthesis by the Hep G2 hepatome cells was determined by incorporation of 3H acetate into sterols and proteins. Lovastatin (200 pg/ml) was used as the control: the sterol synthesis was decreased by 49 +/- 4% without inhibiting the protein synthesis. A number of the cultures produced compounds inhibiting under the experimental conditions the synthesis of sterols by 70 to 80% with simultaneous inhibition of the protein synthesis at least by 60 to 70%. Three compounds from that group produced by streptomycetes were subjected to a more detailed investigation. The compounds were demonstrated to be active antifungal antibiotics (MIC 0.1-1 mcg/ml). In a dose of 0.1-1 mcg/ml they showed high immunosuppressive activity in models of lymphocyte transformation in mice, whereas cyclosporin was active in a dose of 1 mcg/ml. Therefore, the model for screening hypolipidemic compounds could be considered useful for screening promising natural immunosuppressors.
authors.affiliation: National Research Centre of Antibiotics, Moscow.
authors.forename: M V
authors.initials: MV
authors.lastname: Bibikova
authors.forename: N E
authors.initials: NE
authors.lastname: Grammatikova
authors.forename: V V
authors.initials: VV
authors.lastname: Tertov
authors.forename: B V
authors.initials: BV
authors.lastname: Pinegin
authors.forename: Ia V
authors.initials: IaV
authors.lastname: Chmel'
authors.forename: A V
authors.initials: AV
authors.lastname: Katlinskiĭ
mesh_terms: D039903:Actinobacteria / Q000737:chemistry / Q000378:metabolism; D000438:Alcohols / Q000737:chemistry; D000818:Animals; D000935:Antifungal Agents / Q000302:isolation & purification / Q000494:pharmacology*; D045744:Cell Line, Tumor; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D005658:Fungi / Q000737:chemistry / Q000378:metabolism; D022781:Hepatocytes / Q000187:drug effects* / Q000378:metabolism; D000960:Hypolipidemic Agents / Q000494:pharmacology; D007166:Immunosuppressive Agents / Q000302:isolation & purification / Q000494:pharmacology*; D008213:Lymphocyte Activation / Q000187:drug effects; D051379:Mice; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D012988:Soil Microbiology; D013261:Sterols / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D013302:Streptomyces / Q000737:chemistry / Q000378:metabolism
chemical_list: D000438:Alcohols; D000935:Antifungal Agents; D000960:Hypolipidemic Agents; D007166:Immunosuppressive Agents; D011500:Protein Synthesis Inhibitors; D013261:Sterols